US Map / Delaware
State DE

Clinical Trials in Delaware

Recruiting clinical trials with at least one study location in Delaware. Data updated daily from ClinicalTrials.gov.

Total Trials
50
Recruiting Now
50
← Back to US Map
Top Conditions in Delaware
Stage IVB Prostate Cancer AJCC v8 (3)Breast Neoplasms (2)Anatomic Stage II Breast Cancer AJCC v8 (2)Asthma (2)Non Small Cell Lung Cancer (2)Castration-Resistant Prostate Carcinoma (2)Bone Cyst (1)Relapsing Multiple Sclerosis (1)Multiple Sclerosis (1)Advanced Lung Non-Squamous Non-Small Cell Carcinoma (1)Metastatic Lung Non-Squamous Non-Small Cell Carcinoma (1)Recurrent Lung Non-Squamous Non-Small Cell Carcinoma (1)

Frequently Asked Questions — Clinical Trials in Delaware

How many clinical trials are currently recruiting in Delaware?
ClinicalMetric currently tracks 50 actively recruiting clinical trials with at least one location in Delaware. The total number of registered studies—including active but not currently enrolling trials—is 50. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Delaware?
Delaware hosts clinical trials across a broad range of medical conditions, including Stage IVB Prostate Cancer AJCC v8, Breast Neoplasms, Anatomic Stage II Breast Cancer AJCC v8, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Delaware serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Delaware?
To join a clinical trial in Delaware, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Delaware maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Delaware

NCT02193841 Phase 3
Recruiting
Simple Bone Cysts in Kids
Condition
Bone Cyst
Enrollment
160 pts
Location
United States, Australia, Canada
Sponsor
The Hospital for Sick Children
View Trial →
NCT06433752 N/A
Recruiting
A Study Evaluating the Real World Experience of Participants Treated With BRIUMV...
Condition
Relapsing Multiple Sclerosis
Enrollment
500 pts
Location
United States, Puerto Rico
Sponsor
TG Therapeutics, Inc.
View Trial →
NCT04181060 Phase 3
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With E...
Condition
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Enrollment
300 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06770582 Phase 2
Recruiting
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Ther...
Condition
Non-Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
160 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05828069 Phase 2
Recruiting
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapse...
Condition
Recurrent Langerhans Cell Histiocytosis
Enrollment
48 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT02852031 N/A
Recruiting
National Collaborative to Improve Care of Children With Complex Congenital Heart...
Condition
Hypoplastic Left Heart Syndrome (HLHS)
Enrollment
1,000 pts
Location
United States, Canada, United Kingdom
Sponsor
Children's Hospital Medical Ce
View Trial →
NCT07215624 N/A
Recruiting
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Netw...
Condition
Malignant Digestive System Neoplasm
Enrollment
500 pts
Location
United States, Puerto Rico
Sponsor
Wake Forest University Health
View Trial →
NCT06926868 Phase 2, Phase 3
Recruiting
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Prev...
Condition
Breast Neoplasms
Enrollment
500 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
View Trial →
NCT07542301 N/A
Recruiting
Breathing Patterns in Infants Before and After Extubation
Condition
Respiratory Distress Syndrome (RDS)
Enrollment
30 pts
Location
United States
Sponsor
Christiana Care Health Service
View Trial →
NCT05920356 Phase 3
Recruiting
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab P...
Condition
Non-Small Cell Lung Cancer (NSCLC)
Enrollment
750 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
View Trial →
NCT06931340 Phase 3
Recruiting
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormona...
Condition
Castration-Sensitive Prostate Carcinoma
Enrollment
1,260 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT04269902 Phase 3
Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia...
Condition
Chronic Lymphocytic Leukemia
Enrollment
247 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT02235857 N/A
Recruiting
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmen...
Condition
Focal Segmental Glomerulosclerosis
Enrollment
35 pts
Location
United States
Sponsor
Kaneka Medical America LLC
View Trial →
NCT05243797 Phase 3
Recruiting
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Al...
Condition
Multiple Myeloma
Enrollment
1,594 pts
Location
United States, Argentina, Australia
Sponsor
European Myeloma Network B.V.
View Trial →
NCT06058377 Phase 3
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy T...
Condition
Anatomic Stage II Breast Cancer AJCC v8
Enrollment
3,680 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT03488693 Phase 3
Recruiting
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Condition
Breast Cancer
Enrollment
2,140 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
View Trial →
NCT07141277 N/A
Recruiting
GRANITE: Airsupra Effectiveness in the Real World
Condition
Asthma
Enrollment
4,000 pts
Location
United States
Sponsor
AstraZeneca
View Trial →
NCT04616508 N/A
Recruiting
Online Motor Control in People With Parkinson's Disease
Condition
Motor Control
Enrollment
100 pts
Location
United States
Sponsor
University of Delaware
View Trial →
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT06745466 Phase 4
Recruiting
Disentangling the Effects of Daily Stress, Sleep, and Sex Hormones on Accelerate...
Condition
Estrogen
Enrollment
30 pts
Location
United States
Sponsor
University of Delaware
View Trial →
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05946213 Phase 3
Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in...
Condition
Prostate Adenocarcinoma
Enrollment
1,209 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
View Trial →
NCT06592924 Phase 3
Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Ca...
Condition
Prostate Cancer (Adenocarcinoma)
Enrollment
830 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
View Trial →
NCT07174388 N/A
Recruiting
A Study in Non-Small Cell Lung Cancer
Condition
Non Small Cell Lung Cancer
Enrollment
550 pts
Location
United States
Sponsor
N-Power Medicine
View Trial →
NCT04614103 Phase 2
Recruiting
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Condition
Metastatic Non Small Cell Lung Cancer
Enrollment
170 pts
Location
United States, Australia, Canada
Sponsor
Iovance Biotherapeutics, Inc.
View Trial →
Page 1 of 2 — 50 trials total
Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology